Btg Pactual Global Asset Management LTD Bristol Myers Squibb CO Call Options Transaction History

Btg Pactual Global Asset Management LTD

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $13,000 - $7.68 Million	100,000 New	100,000 $7.11 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $973,108 - $1.07 Million	-13,400 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $823,832 - $987,848	13,400 New	13,400 $979,000
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $3.48 Million - $5.06 Million	-75,000 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $3.69 Million - $4.81 Million	-75,000 Reduced 50.0%	75,000 $4.78 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $6.42 Million - $7.61 Million	150,000 New	150,000 $7.61 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $3.03 Million - $3.36 Million	-68,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $3.07 Million - $3.66 Million	68,000 New	68,000 $3.24 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Btg Pactual Global Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Btg Pactual Global Asset Management LTD with notifications on news.